Rituximab, interferon‐alfa‐2b and dose dense CVP is highly efficient in patients with FLIPI ≥ 2 follicular lymphoma. Final results of the LNH‐PRO‐05 study
Sign Up to like & getrecommendations! Published in 2019 at "British Journal of Haematology"
DOI: 10.1111/bjh.15760
Abstract: Sarah Davis Steve Goodacre Abdullah Pandor Daniel Horner John W. Stevens Kerstin de Wit Beverley J. Hunt ScHARR, University of Sheffield, Sheffield, UK, Emergency Department, Salford Royal NHS Foundation Trust, Salford, UK, Department of Medicine,… read more here.
Keywords: interferon alfa; alfa dose; dense cvp; rituximab interferon ... See more keywords